Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B B Vargaftig

Showing results (11-20 of 324) with videos related to

Pageof 33
Sort By:
Agents and Actions|December 1, 1994
The pharmacology of slow reacting substance C and of arachidonic acid. 1973B B Vargaftig
Archives Francaises De Pediatrie|January 1, 1982
[Mediators of inflammation. Their nature and their role]B B Vargaftig
The Journal of Pharmacy and Pharmacology|February 1, 1978
Salicylic acid fails to inhibit generation of thromboxane A2 activity in platelets after in vivo administration to the ratB B Vargaftig
International Angiology : a Journal of the International Union of Angiology|April 1, 1988
Biochemical mediators involved in the inflammatory reaction. Protective activity of S 5682B B Vargaftig
Agents and Actions|July 1, 1976
Aspects of release of pharmacologically active substances from the lungs by chemical stimuliB B Vargaftig
Annales De L'Institut Pasteur. Immunologie|September 1, 1985
Leukotrienes and immediate hypersensitivityB B Vargaftig
Annales De L'Institut Pasteur. Immunologie|September 1, 1985
Do leukotrienes account for antigen-induced bronchoconstriction in the guinea-pig?B B Vargaftig
Research in Immunology|January 1, 1997
Biology of airway inflammation: from immunology to altered responsivenessB B Vargaftig
Agents and Actions. Supplements|January 1, 1977
Involvement of mediators in the interaction of platelets and carrageenanB B Vargaftig
The Journal of Pharmacy and Pharmacology|April 1, 1977
Carrageenan and thrombin trigger prostaglandin synthetase-independent aggregation of rabbit platelets: inhibition by phospholipase A2 inhibitorsB B Vargaftig
Pageof 33

Showing results (11-20 of 324) with videos related to

Sort By:
Pageof 33
Agents and Actions|December 1, 1994
The pharmacology of slow reacting substance C and of arachidonic acid. 1973B B Vargaftig
Archives Francaises De Pediatrie|January 1, 1982
[Mediators of inflammation. Their nature and their role]B B Vargaftig
The Journal of Pharmacy and Pharmacology|February 1, 1978
Salicylic acid fails to inhibit generation of thromboxane A2 activity in platelets after in vivo administration to the ratB B Vargaftig
International Angiology : a Journal of the International Union of Angiology|April 1, 1988
Biochemical mediators involved in the inflammatory reaction. Protective activity of S 5682B B Vargaftig
Agents and Actions|July 1, 1976
Aspects of release of pharmacologically active substances from the lungs by chemical stimuliB B Vargaftig
Annales De L'Institut Pasteur. Immunologie|September 1, 1985
Leukotrienes and immediate hypersensitivityB B Vargaftig
Annales De L'Institut Pasteur. Immunologie|September 1, 1985
Do leukotrienes account for antigen-induced bronchoconstriction in the guinea-pig?B B Vargaftig
Research in Immunology|January 1, 1997
Biology of airway inflammation: from immunology to altered responsivenessB B Vargaftig
Agents and Actions. Supplements|January 1, 1977
Involvement of mediators in the interaction of platelets and carrageenanB B Vargaftig
The Journal of Pharmacy and Pharmacology|April 1, 1977
Carrageenan and thrombin trigger prostaglandin synthetase-independent aggregation of rabbit platelets: inhibition by phospholipase A2 inhibitorsB B Vargaftig
Pageof 33